BioLineRx (NASDAQ:BLRX) Earnings Information
BioLineRx last released its quarterly earnings results on November 23rd, 2020. The biotechnology company reported ($0.30) EPS for the quarter, beating analysts' consensus estimates of ($0.36) by $0.06. BioLineRx has generated ($2.55) earnings per share over the last year. BioLineRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 19th, 2021 based off prior year's report dates.
BioLineRx Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
BioLineRx (NASDAQ:BLRX) Earnings Estimates
2021 EPS Consensus Estimate: ($0.62)
BioLineRx (NASDAQ BLRX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)